PK and Safety Study of Paclitaxel Injection Concentrate for Nano-dispersion Administered Weekly

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Sun Pharma Advanced Research Company Limited
ClinicalTrials.gov Identifier:
NCT01305512
First received: February 24, 2011
Last updated: December 15, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)